High-risk phenotypes
Intermediate-risk phenotypes
Defined phenotype epidemiologically not associated with cancer
|
3
2
0
|
Laboratory level |
|
High-risk antibody (>70% cancer association)
Intermediate risk antibody (30%–70%)
Lower risk antibody (<30%) or negative
|
3
2
0
|
Cancer |
|
Found, consistent with phenotype and (if present) antibody, or
not consistent but antigen expression demonstrated
Not found (or not consistent) but follow-up <2 y
Not found and follow-up ≥2y
|
4
1
0
|
Diagnostic level |
Total points |
Definite
Probable
Possible
Non-PNS
|
≥8
6-7
4-5
≤3
|